Stillbirth rate is an indirect measure of the quality of management of pregnancy, labour and delivery. The loss of a baby due to stillbirth does not only affect pregnant women but also takes a great toll on family’s health and wellbeing. In Ghana, stillbirths account for a large proportion of perinatal mortalities. We used small multiple graphs to compare the rate of stillbirth in the Volta region from (2014-2016) to the national target for stillbirth.

Inferences from the graph shows that there was a gap of 10.4 per 1,000 live births between the national target of 12 per 1,000 live births. Fresh still birth also had a mean of 37.2 per 1000 live births showing a gap of 25.2 between the national target. The gap between the national target and macerated still birth is 50.8. This shows significant change in the stillbirth rate in the region and requires attention. In view of this, this study aims to reduce stillbirth (macerated) by 50% in two years period.

The authors have declared no competing interest.

This study did not receive any funding

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Institutional Review Board of University of Cape Coast, Ghana waived ethical approval for this work.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes